Evidence map›Paper›PMID 41838909›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

High-affinity, structure-validated and selective macrocyclic peptide tools for chemical biology studies of Huntingtin.

Rebeka Fanti, Esther Wolf, Tatsuya Ikenoue, Justin C Deme, Swati Balakrishnan, Brandon A Keith, Matthew G Alteen, Renu Chandrasekaran, Manisha Yadav, Ritika Bhajiawala and 8 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Rebeka Fanti *Structural Genomics Consortium, University Health Network, Toronto, ON M5G 1L7, Canada.ORCID 0000-0001-9995-5875
Esther Wolf *Structural Genomics Consortium, University Health Network, Toronto, ON M5G 1L7, Canada.
Tatsuya IkenoueDepartment of Chemistry, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.
Justin C DemeCenter for Structural Biology, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702.ORCID 0000-0001-8811-9871
Swati BalakrishnanStructural Genomics Consortium, University Health Network, Toronto, ON M5G 1L7, Canada.ORCID 0000-0002-2903-0604
Brandon A KeithStructural Genomics Consortium, University Health Network, Toronto, ON M5G 1L7, Canada.
Matthew G AlteenStructural Genomics Consortium, University Health Network, Toronto, ON M5G 1L7, Canada.ORCID 0000-0002-9639-7668
Renu ChandrasekaranStructural Genomics Consortium, University Health Network, Toronto, ON M5G 1L7, Canada.ORCID 0000-0001-7593-2476
Manisha YadavStructural Genomics Consortium, University Health Network, Toronto, ON M5G 1L7, Canada.ORCID 0000-0001-6559-7774
Ritika BhajiawalaStructural Genomics Consortium, University Health Network, Toronto, ON M5G 1L7, Canada.
Suzanne AcklooStructural Genomics Consortium, University Health Network, Toronto, ON M5G 1L7, Canada.
Jia FengDepartment of Medical Genetics, Vancouver, BC V5Z 4H4, Canada.ORCID 0000-0002-9134-6108
Mahmoud A PouladiDepartment of Medical Genetics, Vancouver, BC V5Z 4H4, Canada.ORCID 0000-0002-9030-0976
Aled M EdwardsStructural Genomics Consortium, University Health Network, Toronto, ON M5G 1L7, Canada.ORCID 0000-0002-4782-6016
Derek J WilsonDepartment of Chemistry, York University, Toronto, ON M3J 1P3, Canada.
Susan M LeaCenter for Structural Biology, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702.
Hiroaki SugaDepartment of Chemistry, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.ORCID 0000-0002-5298-9186
Rachel J HardingStructural Genomics Consortium, University Health Network, Toronto, ON M5G 1L7, Canada.ORCID 0000-0002-1134-391X

Funding

Canadian Institutes of Health Research (CIHR) 198025EUbOPEN: Enabling and Unlocking biology in the OPEN 875510MEXT | Japan Society for the Promotion of Science (JSPS) JP20H05618Mitacs (Mitacs Inc.) IT21124Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN-2024-05769
6 · The paper itself

Abstract

Huntington's disease (HD) is a fatal neurodegenerative disorder caused by a Cytosine-Adenosine-Guanine (CAG) repeat expansion in the

Indexed as

Huntingtin ProteinMacrocyclic CompoundsPeptidesAnimalsHumansHuntington DiseaseNuclear ProteinsProtein BindingHAP40 protein, humanHTT protein, humanHuntingtin ProteinMacrocyclic CompoundsNuclear ProteinsPeptidesHAP40HuntingtinHuntington diseasemacrocycles

Identifiers

PMID41838909
PMCPMC13012115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.